Antares Pharma reported $29.76M in Gross Profit on Sales for its fourth fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Gross Profit On Sales Change
Abbott ABT:US USD 5.78B 543M
Aerie Pharmaceuticals AERI:US USD 29.2M 370K
Ani Pharmaceuticals ANIP:US USD 50.93M 12.37M
Atrion ATRI:US USD 20.83M 3.46M
Becton, Dickinson and BDX:US USD 2.08B 9M
Cara Therapeutics CARA:US USD 7.76M 15.24M
Eli Lilly And LLY:US USD 5.36B 305M
Endo International Ordinary Shares ENDP:US USD 364.83M 28.49M
Meridian Bioscience VIVO:US USD 33.99M 2.74M
Orasure Technologies OSUR:US USD 46.19M 18.61M
Pacira Pharmaceuticals PCRX:US USD 116.79M 2M
Pfizer PFE:US USD 16.55B 2.52B
Revance Therapeutics RVNC:US USD 18.28M 566K
Teva Pharmaceutical TEVA:IT USD 1.71B 118M
Teva Pharmaceutical Industries TEVA:US USD 1.71B 118M